Legal & General Group PLC Apellis Pharmaceuticals, Inc. Transaction History
Legal & General Group PLC
- $470 Billion
- Q3 2024
A detailed history of Legal & General Group PLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 97,650 shares of APLS stock, worth $3.19 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97,650
Previous 97,650
-0.0%
Holding current value
$3.19 Million
Previous $2.82 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding APLS
# of Institutions
308Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$509 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$389 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$363 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$321 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$189 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.59B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...